Santhera Pharmaceuticals Holding (SPHDF)
OTHER OTC:SPHDF
Holding SPHDF?
Track your performance easily

Santhera Pharmaceuticals Holding (SPHDF) Financial Statements

31 Followers

Santhera Pharmaceuticals Holding Financial Overview

Santhera Pharmaceuticals Holding's market cap is currently ―. The company's EPS TTM is $6.697; its P/E ratio is 1.75; Santhera Pharmaceuticals Holding is scheduled to report earnings on April 24, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsCHF 12.70MCHF 21.21MCHF 7.99MCHF 12.41MCHF 19.35M
Total AssetsCHF 79.78MCHF 91.12MCHF 80.22MCHF 88.69MCHF 100.07M
Total DebtCHF 40.64MCHF 42.98MCHF 43.37MCHF 71.17MCHF 61.64M
Net DebtCHF 27.94MCHF 21.77MCHF 35.38MCHF 58.76MCHF 42.29M
Total LiabilitiesCHF 93.63MCHF 89.79MCHF 71.86MCHF 95.04MCHF 99.86M
Stockholders EquityCHF -13.85MCHF 1.33MCHF 8.35MCHF -6.35MCHF 210.00K
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in CHF

Santhera Pharmaceuticals Holding Earnings and Revenue History

Santhera Pharmaceuticals Holding Debt to Assets

Santhera Pharmaceuticals Holding Cash Flow

Santhera Pharmaceuticals Holding Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis